ATARA BIOTHERAPEUTICS, INC. Shareholders' Equity
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Shareholders' Equity of -$37.00 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent -$37.00M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$37.31M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$38.50M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$36.63M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$37.00M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | -$37.31M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | -$38.50M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | -$36.63M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$35.04M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | -$55.07M 10-Q · filed 2026-08-12 | |
| 2024-12-31 | -$97.28M 10-Q · filed 2026-08-12 | |
| 2024-09-30 | -$90.54M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$110.87M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | -$98.31M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $99.23M 10-K · filed 2026-03-16 | -$99.23M 10-K · filed 2024-03-28 |
| 2023-09-30 | -$50.84M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $7.45M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $64.96M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $126.64M 10-K · filed 2025-03-07 | |
| 2022-09-30 | $187.11M 10-Q · filed 2023-11-01 | |
| 2022-06-30 | $257.48M 10-Q · filed 2023-11-01 | |
| 2022-03-31 | $224.32M 10-Q · filed 2023-11-01 | |
| 2021-12-31 | $279.61M 10-K · filed 2024-03-28 | |
| 2021-09-30 | $310.14M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $331.54M 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $399.04M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $462.34M 10-K · filed 2023-02-08 | |
| 2020-09-30 | $353.94M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $381.13M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $252.82M 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $290.78M 10-K · filed 2023-02-08 | |
| 2019-09-30 | $318.44M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $232.28M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $283.93M 10-Q · filed 2020-11-09 | |
| 2018-12-31 | $339.22M 10-K · filed 2022-02-28 | $338.86M 10-K · filed 2019-02-26 |
| 2018-09-30 | $403.05M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $452.50M 10-Q · filed 2019-11-07 | |
| 2018-03-31 | $439.18M 10-Q · filed 2019-11-07 | |
| 2017-12-31 | $177.86M 10-K · filed 2021-03-01 | |
| 2017-09-30 | $205.96M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $221.14M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $233.13M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $253.74M 10-K · filed 2020-02-27 | |
| 2016-09-30 | $270.20M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $290.25M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $303.83M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $315.10M 10-K · filed 2019-02-26 | |
| 2015-09-30 | $333.75M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $149.25M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $166.09M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $103.18M 10-K · filed 2018-02-27 | |
| 2014-09-30 | -$23.03M 10-Q · filed 2014-11-12 | |
| 2013-12-31 | -$11.02M 10-K · filed 2017-03-09 | |
| 2012-12-31 | -$3.73M 10-K · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |